Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ibandronic acid versus zoledronic acid for painful skeletal metastases
2004-001854-10Phase 3Completed
- Sponsor
- Roche
- Start
- Dec 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in bone metastases comparing Bondronat arm with Zometa arm (2 arms). Primary endpoint: Pain response. Started Dec 2004; status: completed.
02
Drugs
ibandronic acidzoledronic acid
03
Conditions
bone metastases
Beyond the preview
Go deeper on 2004-001854-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-001854-10.